Weill Cornell Medicine receives $17.4 million grant to shorten tuberculosis treatment
Researchers at Weill Cornell Medicine have received a $17.4 million, five-year grant from the National Institute of Allergy and Infectious Diseases to discover new approaches to shorten tuberculosis (TB) treatment,…